I'm Just a Bill: Lower Costs, More Transparency Act

👀 I’m Just a Bill — Lower Costs, More Transparency Act A Liana Banyan “I’m Just a Bill” Bounty Poster What is this bill? Healthcare-cost transparency and Pharmacy Benefit Manager (PBM) reform legislation in the 119th Congress. Focuses on hospital-price transparency, PBM transparency, and direct-to-consumer drug pricing. What does it actually do? Hospital price transparency: Strengthens existing CMS price-transparency rules; adds enforcement. PBM transparency: Requires PBMs to disclose rebate structures and pass-through pricing arrangements. Drug coupons: Modifies Medicare/Medicaid treatment of manufacturer drug coupons. Site-neutral payments: Adjusts Medicare payment differentials between hospital-outpatient and physician-office settings for the same procedures. PBM reform: Specific provisions limiting PBM “spread pricing” and clawback practices. Who votes when? House Energy & Commerce + Ways & Means + Senate Finance + HELP active consideration. How does this affect cooperative-class families? Composes directly with three cooperative-healthcare initiatives: ...

May 12, 2026 · 1 min · 195 words · Liana Banyan Corporation

I'm Just a Bill: Medicare Drug Price Negotiation Expansion

👀 I’m Just a Bill — Medicare Drug Price Negotiation Expansion A Liana Banyan “I’m Just a Bill” Bounty Poster What is this bill? Expansion of Medicare’s drug-price negotiation authority (established in the 2022 IRA) in the 119th Congress. Current proposals expand the number of drugs subject to negotiation and accelerate the implementation timeline. What does it actually do? Drug count: Increases the number of high-cost drugs CMS can negotiate annually Timeline: Accelerates eligibility-after-launch threshold Insulin/inhalers: Specific provisions for these drug classes Part B + Part D: Extends negotiation authority to Part B (physician-administered) drugs Penalties: Strengthens manufacturer-noncompliance penalties Who votes when? Senate Finance + House Ways & Means + Energy & Commerce active consideration How does this affect cooperative-class families? Composes with #6 Tatiana Schlossberg Health Accords drug-pricing transparency, #7 MSA Substitution-routing economics, and the Affordable Insulin Now Act + Lower Costs More Transparency Act Bounty Posters. ...

May 12, 2026 · 1 min · 159 words · Liana Banyan Corporation